The release of secreted HSP60 in response to inflammation has been observed in blood, either through the classical (ER and Golgi vesicles) or non-classical (by lipid raft–exosome) pathways, in various cancers and cardiomyopathy [140]. Here, HSPD1 is linked to cancer.